Ksilidin

Ksilidin may be available in the countries listed below.

Ingredient matches for Ksilidin

Lidocaine

Lidocaine is reported as an ingredient of Ksilidin in the following countries:

• Turkey

International Drug Name Search

Nidicard

Nidicard may be available in the countries listed below.

Ingredient matches for Nidicard

Nifedipine

Nifedipine is reported as an ingredient of Nidicard in the following countries:

• Turkey

International Drug Name Search

Meperidina Richmond

Meperidina Richmond may be available in the countries listed below.

Ingredient matches for Meperidina Richmond

Pethidine

Pethidine hydrochloride (a derivative of Pethidine) is reported as an ingredient of Meperidina Richmond in the following countries:

• Argentina

International Drug Name Search

Perinase

Perinase may be available in the countries listed below.

Ingredient matches for Perinase

Fluticasone

Fluticasone propionate (a derivative of Fluticasone) is reported as an ingredient of Perinase in the following countries:

• Bangladesh

International Drug Name Search

Lisinopril Alpharma

Lisinopril Alpharma may be available in the countries listed below.

Ingredient matches for Lisinopril Alpharma

Lisinopril

Lisinopril dihydrate (a derivative of Lisinopril) is reported as an ingredient of Lisinopril Alpharma in the following countries:

• Portugal

International Drug Name Search

Idiopathic Pulmonary Fibrosis Medications

Definition of Idiopathic Pulmonary Fibrosis: Idiopathic pulmonary fibrosis involves scarring or thickening of tissues deep in the lung without a known cause.

Drugs associated with Idiopathic Pulmonary Fibrosis

The following drugs and medications are in some way related to, or used in the treatment of Idiopathic Pulmonary Fibrosis. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

Learn more about Idiopathic Pulmonary Fibrosis

Medical Encyclopedia:

• Idiopathic pulmonary fibrosis

Drug List:

Actimmune

Dipivefrina

Dipivefrina may be available in the countries listed below.

Ingredient matches for Dipivefrina

Dipivefrine

Dipivefrina (DCIT) is also known as Dipivefrine (Rec.INN)

International Drug Name Search

Glossary

DCIT	Denominazione Comune Italiana
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Lerdip

Lerdip may be available in the countries listed below.

Ingredient matches for Lerdip

Lercanidipine

Lercanidipine hydrochloride (a derivative of Lercanidipine) is reported as an ingredient of Lerdip in the following countries:

• Netherlands

International Drug Name Search

Cefadin

Cefadin may be available in the countries listed below.

Ingredient matches for Cefadin

Cefalexin

Cefalexin is reported as an ingredient of Cefadin in the following countries:

• Ecuador

Cefalotin

Cefalotin sodium salt (a derivative of Cefalotin) is reported as an ingredient of Cefadin in the following countries:

• Singapore

Cefradine

Cefradine is reported as an ingredient of Cefadin in the following countries:

• Bangladesh

International Drug Name Search

Milophene

In the US, Milophene is a member of the drug class synthetic ovulation stimulants and is used to treat Female Infertility, Lactation Suppression, Oligospermia and Ovulation Induction.

Ingredient matches for Milophene

Clomifene

Clomifene citrate (a derivative of Clomifene) is reported as an ingredient of Milophene in the following countries:

• United States

International Drug Name Search

Sirdalud

Sirdalud may be available in the countries listed below.

Ingredient matches for Sirdalud

Tizanidine

Tizanidine is reported as an ingredient of Sirdalud in the following countries:

• Luxembourg


• Serbia

Tizanidine hydrochloride (a derivative of Tizanidine) is reported as an ingredient of Sirdalud in the following countries:

• Argentina


• Austria


• Bangladesh


• Belgium


• Brazil


• Chile


• Colombia


• Czech Republic


• Denmark


• Estonia


• Finland


• Georgia


• Germany


• Ghana


• Greece


• Guyana


• Hungary


• India


• Indonesia


• Italy


• Kenya


• Latvia


• Libya


• Lithuania


• Mexico


• Netherlands


• Nigeria


• Oman


• Philippines


• Poland


• Portugal


• Russian Federation


• Serbia


• Slovakia


• Slovenia


• Spain


• Sudan


• Switzerland


• Taiwan


• Tanzania


• Thailand


• Turkey


• Venezuela


• Vietnam


• Zimbabwe

International Drug Name Search

Solutio Cordes Dexa N

Solutio Cordes Dexa N may be available in the countries listed below.

Ingredient matches for Solutio Cordes Dexa N

Dexamethasone

Dexamethasone is reported as an ingredient of Solutio Cordes Dexa N in the following countries:

• Germany

International Drug Name Search

Ceftin

Ceftin is a brand name of cefuroxime, approved by the FDA in the following formulation(s):

CEFTIN (cefuroxime axetil - for suspension; oral)

• 
  Manufacturer: GLAXOSMITHKLINE
  
  Approval date: June 30, 1994
  
  Strength(s): EQ 125MG BASE/5ML ^[AB]


• 
  Manufacturer: GLAXOSMITHKLINE
  
  Approval date: April 29, 1997
  
  Strength(s): EQ 250MG BASE/5ML ^[RLD][AB]

CEFTIN (cefuroxime axetil - tablet; oral)

• 
  Manufacturer: GLAXOSMITHKLINE
  
  Approval date: December 28, 1987
  
  Strength(s): EQ 125MG BASE ^[AB], EQ 250MG BASE ^[AB], EQ 500MG BASE ^[RLD][AB]

Has a generic version of Ceftin been approved?

Yes. The following products are equivalent to Ceftin:

cefuroxime axetil for suspension; oral

• 
  Manufacturer: RANBAXY
  
  Approval date: February 5, 2008
  
  Strength(s): EQ 125MG BASE/5ML ^[AB], EQ 250MG BASE/5ML ^[AB]

cefuroxime axetil tablet; oral

• 
  Manufacturer: ALKEM LABS LTD
  
  Approval date: June 7, 2010
  
  Strength(s): EQ 250MG BASE ^[AB], EQ 500MG BASE ^[AB]


• 
  Manufacturer: APOTEX
  
  Approval date: October 2, 2002
  
  Strength(s): EQ 250MG BASE ^[AB], EQ 500MG BASE ^[AB]


• 
  Manufacturer: AUROBINDO PHARMA LTD
  
  Approval date: March 29, 2006
  
  Strength(s): EQ 125MG BASE ^[AB], EQ 250MG BASE ^[AB], EQ 500MG BASE ^[AB]


• 
  Manufacturer: LUPIN
  
  Approval date: July 25, 2003
  
  Strength(s): EQ 250MG BASE ^[AB], EQ 500MG BASE ^[AB]


• 
  Manufacturer: ORCHID HLTHCARE
  
  Approval date: February 15, 2008
  
  Strength(s): EQ 125MG BASE ^[AB], EQ 250MG BASE ^[AB], EQ 500MG BASE ^[AB]


• 
  Manufacturer: RANBAXY
  
  Approval date: February 15, 2002
  
  Strength(s): EQ 125MG BASE ^[AB], EQ 250MG BASE ^[AB], EQ 500MG BASE ^[AB]


• 
  Manufacturer: RANBAXY
  
  Approval date: April 25, 2003
  
  Strength(s): EQ 125MG BASE ^[AB], EQ 250MG BASE ^[AB], EQ 500MG BASE ^[AB]


• 
  Manufacturer: TEVA
  
  Approval date: October 18, 2004
  
  Strength(s): EQ 250MG BASE ^[AB], EQ 500MG BASE ^[AB]


• 
  Manufacturer: WOCKHARDT
  
  Approval date: July 29, 2005
  
  Strength(s): EQ 125MG BASE ^[AB], EQ 250MG BASE ^[AB], EQ 500MG BASE ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Ceftin. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Ceftin.

See also...

• Ceftin Consumer Information (Drugs.com)
• Ceftin Consumer Information (Wolters Kluwer)
• Ceftin Suspension Consumer Information (Wolters Kluwer)
• Ceftin Consumer Information (Cerner Multum)
• Ceftin Advanced Consumer Information (Micromedex)
• Cefuroxime Consumer Information (Wolters Kluwer)
• Cefuroxime Suspension Consumer Information (Wolters Kluwer)
• Cefuroxime Tablets Consumer Information (Wolters Kluwer)
• Cefuroxime Consumer Information (Cerner Multum)
• Cefuroxime Advanced Consumer Information (Micromedex)
• Cefuroxime Injection, Intravenous Advanced Consumer Information (Micromedex)
• Cefuroxime Axetil AHFS DI Monographs (ASHP)
• Cefuroxime Sodium AHFS DI Monographs (ASHP)